Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Cancer Genetics Inc (CGIX)

3.85 +0.05 (+1.32%)

6/23/2017  4:00pm

Open:

3.85

Pre. Close:

3.80

High:

3.90

Low:

3.70

Volume:

88,896

Market Cap:

76.08M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

3.95 - 4.02

4.02 - 4.1

Low:

3.56 - 3.61

3.61 - 3.67

Close:

3.75 - 3.86

3.86 - 3.99

Technical analysis  (as of: 2017-06-23 4:33:07 PM)

Overall:

      

Stoxline posted a BUY today, upgraded from lower rating. This stock seems to be ready for a new bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, a new upward move is expected.

Target:

Six months: 4.70     One year: 5.08

Support:

Support1: 3.50    Support2: 2.91

Resistance:

Resistance1: 4.03    Resistance2: 4.35

Pivot:

3.83

Moving Averages:

MA(5): 3.82     MA(20): 3.86

MA(100): 3.33     MA(250): 2.40

MACD:

MACD(12,26): -0.03     Signal(12,26,9): -0.02

%K %D:

%K(14,3): 37.25     %D(3): 36.60

RSI:

RSI(14): 50.00

52-Week:

High: 5.30  Low: 1.10  Change(%): 87.8

Average Vol(K):

3-Month: 367  10-Days 151

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
CGIX has closed below upper band by 45.9%. Bollinger Bands are 52.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to CGIX's normal range. The bands have been in this narrow range for 15 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Fri, 02 Jun 2017 12:00:00 GMT
Cancer Genetics, Inc. to Present at the 7th Annual LD Micro Invitational

Mon, 08 May 2017 11:32:55 GMT
Cancer Genetics, Inc. Changes The Paradigm For Lung Cancer Monitoring ...

Wed, 22 Feb 2017 13:12:44 GMT
Cancer Genetics, Inc. to Receive $1.0 Million in Non-Dilutive Funding Through ...

Mon, 13 Mar 2017 13:14:25 GMT
Cancer Genetics to Present at "A Future Without Cancer Conference" on Friday ...

Mon, 19 Jun 2017 11:03:45 GMT
Cancer Genetics Inc (NASDAQ:CGIX) Sentiment Worsened, Because

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Healthcare Facilities Services

Shares Out. (M)

19.76

Shares Float (M)

14.25

% Held by Insiders

28.89

% Held by Institutions

16.50

Shares Short (K)

2030

Shares Short Prior Month (K)

1730

Stock Financials

EPS

-1.180

EPS Est. Current Year

-0.860

EPS Est. Next Year

0.090

EPS Est. Next Quarter

-0.120

Forward EPS

0.090

Book Value (p.s.)

1.060

PEG Ratio

-0.11

Profit Margin

-72.03

Operating Margin

-51.32

Return on Assets (ttm)

-20.5

Return on Equity (ttm)

-81.8

Qtrly Rev. Growth

14.8

Gross Profit (p.s.)

0.504

Sales Per Share

EBITDA (p.s.)

-0.605

Qtrly Earnings Growth

Operating Cash Flow (M)

-14.46

Levered Free Cash Flow (M)

-9.64

FoxReading.com

Valuation

P/E

-3.26

P/E Growth Ratio

0.01

P/BV

3.63

P/S

46960492.00

P/CF

-5.26

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

2016-09-02

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.